Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Gastric Cancer Diagnostic Procedure Market from 2024 to 2025?

In recent years, the market size for gastric cancer diagnostic procedures has seen robust growth. The market is projected to expand from $1.44 billion in 2024 to $1.54 billion in 2025, registering a compound annual growth rate (CAGR) of 7.3%. The historical growth can be linked to technological breakthroughs in biopsy methods, a surge in research funding, advancements in biomarker discovery, enhancements in pathological analysis, and changes in screening guidelines.

What Is the Projected Market Size of the Gastric Cancer Diagnostic Procedure Market?

Expectations are high for robust expansion in the gastric cancer diagnostic procedure market size in the coming years. Its growth is projected to reach $2.07 billion by 2029, with a compound annual growth rate (CAGR) of 7.6%. The momentum during the forecast period is primarily due to the upsurge in point-of-care testing, advancements in biomarkers, a shift towards personalized medicine, the acceptance of next-generation sequencing, and improved endoscopic imaging modalities. Key trends in the forecast period encompass the incorporation of nanotechnology, embracing big data analytics, the use of microbiota analysis, increased focus on patient-centric approaches, and the application of telehealth in diagnostics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12038&type=smp

Who are the Major Competitors in the Gastric Cancer Diagnostic Procedure Market Outlook?

Major companies operating in the gastric cancer diagnostic procedure market include Pfizer Inc., Johnson & Johnson Co, F. Hoffmann La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories Inc., Sanofi SA, Eli Lilly and Company, Otsuka Pharmaceutical Co Ltd., AdventHealth, Atrium Health, Astellas Pharma Inc, Bausch Health Companies Inc., Agilent Technologies Inc., Ipsen Pharma, Hartford HealthCare, Myriad Genetics Inc., NovoCure Limited, Foundation Medicine Inc., Biocept Inc.

What Is Fueling Growth in the Gastric Cancer Diagnostic Procedure Market?

The escalating incidence of gastrointestinal ailments is a key factor propelling the expansion of the gastric cancer diagnostic procedure market. These ailments encapsulate a range of conditions that impact the numerous segments of the digestive system, as well as supportive organs like the liver and pancreas. Procedures for diagnosing gastric cancer, such as endoscopy and biopsy, are quintessential in the treatment of stomach cancer. Thus, the surge in gastrointestinal diseases is acting as a catalyst for the growth of the gastric cancer diagnostic procedure market. In August 2022, GI Associates & Endoscopy Center, a medical facility in the US specializing in gastroenterology services, published a report which indicated that out of 73,076 individuals across 33 countries included in a study, a substantial 40% were suffering from a functional gastrointestinal ailment. Therefore, the increasing rate of gastrointestinal illnesses is playing a significant role in facilitating the growth of the gastric cancer diagnostic procedure market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12038&type=smp

Which Gastric Cancer Diagnostic Procedure Market Segments Are Growing the Fastest?

The gastric cancer diagnostic procedure market covered in this report is segmented –

1) By Procedure Type: Endoscopic Procedure, Biopsy, Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types

2) By Symptom Type: Symptomatic, Asymptomatic

3) By Offering Type: Instruments, Reagents And Consumables, Services

4) By Body Fluid Type: Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid

5) By Disease Indication: Early Gastric Cancer, Advanced Gastric Cancer

Subsegments:

1) By Endoscopic Procedure: Upper Endoscopy (EGD), Endoscopic Ultrasound (EUS)

2) By Biopsy: Endoscopic Biopsy, Fine Needle Aspiration (FNA) Biopsy

3) By Tissue Tests: Histopathology, Immunohistochemistry

4) By Lab Tests: Blood Tests, Tumor Markers

5) By In-Vitro Diagnostic Tests: Genetic Testing, Molecular Profiling

6) By Imaging Tests: Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scan

7) By Molecular Diagnostics: PCR Testing, Next-Generation Sequencing (NGS)

8) By Multiplexing Molecular Diagnostics: Multiplex PCR, Microarray Analysis

9) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)

10) By Other Procedure Types: Breath Tests, Liquid Biopsies

Which Industry Trends Are Shaping the Future of the Gastric Cancer Diagnostic Procedure Market?

The growing significance of technological advancements is a notable trend in the gastric cancer diagnostic market. In an effort to maintain their market presence, major firms in this sector are embracing new technologies. For instance, Ibex Medical Analytics, a healthcare diagnostics provider from Israel that specializes in artificial intelligence, rolled out Galen Gastric in June 2022, the first of its kind in the world for gastric cancer detection. Galen Gastric is a comprehensive diagnostic tool designed to assist pathologists in detecting stomach cancer, H. pylori, and other crucial clinical findings. It also improves diagnostic workflows and speeds up response times.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report

Which Countries Are Leading the Gastric Cancer Diagnostic Procedure Market?

North America was the largest region in the gastric cancer diagnostics procedure market in 2024. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12038

This Report Delivers Insight On:

1. How big is the gastric cancer diagnostic procedure market, and how is it changing globally?

2. Who are the major companies in the gastric cancer diagnostic procedure market, and how are they performing?

3. What are the key opportunities and risks in the gastric cancer diagnostic procedure market right now?

4. Which products or customer segments are growing the most in the gastric cancer diagnostic procedure market?

5. What factors are helping or slowing down the growth of the gastric cancer diagnostic procedure market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model